TruDiagnostic TruAge Complete: Epigenetic Age Testing and the Science of Measuring How Fast You Are Aging

The most comprehensive consumer epigenetic age test on the market measures not just how old your cells appear but how fast they are aging. Does the science of DNA methylation clocks justify the $499 price tag?

Presented By Our Partners

In 2013, Steve Horvath, a geneticist at UCLA, published a landmark paper that fundamentally changed how scientists think about aging. By analyzing DNA methylation patterns at 353 specific CpG sites across the genome, Horvath demonstrated that biological age, the rate at which cells and tissues actually deteriorate, can be measured with remarkable precision and that it often diverges significantly from chronological age. Two 50-year-olds might share a birthday but differ by a decade or more in biological age, and it is the biological number, not the calendar one, that predicts disease risk, functional decline, and mortality. A 2018 study published in the journal Aging by Levine et al. at UCLA extended this work, developing DNAm PhenoAge, an epigenetic biomarker that strongly outperformed previous measures in predicting all-cause mortality, cancer, physical functioning, and Alzheimer’s disease across multiple large cohorts. A 2021 study in The Journals of Gerontology by McCrory et al. found that the GrimAge clock significantly outperformed three other epigenetic clocks in predicting eight of nine clinical outcomes, including walking speed, frailty, polypharmacy, and mortality, in a cohort of 490 participants followed for up to 10 years. TruDiagnostic, founded in 2020 in Lexington, Kentucky, built its TruAge Complete test to make this science accessible to consumers, offering the most comprehensive panel of epigenetic age algorithms available outside a research laboratory.

What Is TruDiagnostic TruAge Complete?

TruDiagnostic TruAge Complete is an at-home blood test that measures biological age through DNA methylation analysis. Users collect a small blood sample via finger prick, mail it to TruDiagnostic’s CLIA-certified laboratory, and receive a comprehensive report within 4 to 6 weeks. The report includes results from multiple epigenetic clock algorithms, each measuring a different dimension of biological aging.

The test panel includes OMICmAge (TruDiagnostic’s proprietary multi-omic age algorithm), DunedinPACE (the “pace of aging” clock developed at Duke University that measures how fast you are currently aging, expressed as years of biological aging per calendar year), GrimAge (the most powerful mortality predictor among current epigenetic clocks), PhenoAge (optimized for healthspan prediction), and the original Horvath clock. Additionally, the report provides organ system ages for multiple biological systems, immune cell composition analysis, telomere length estimation, and a comparison against TruDiagnostic’s reference database of other users.

TruDiagnostic positions TruAge Complete as a longitudinal tool, not a one-time test. The company recommends retesting every 3 to 6 months to track how lifestyle interventions, supplements, or medical treatments are affecting the pace of biological aging over time. This longitudinal use case, using biological age as a biomarker of intervention effectiveness, is one of the most compelling applications of epigenetic testing.

The Science Behind It: Epigenetic Clocks and Mortality Prediction

Epigenetic clocks are algorithms that calculate biological age from patterns of DNA methylation, chemical modifications to DNA that regulate gene expression without altering the underlying genetic sequence. Unlike inherited genetic variants (which remain fixed from birth), DNA methylation patterns change over time in response to aging, environmental exposures, lifestyle factors, and disease processes. This makes methylation a dynamic biomarker that reflects both cumulative health history and current biological state.

The 2018 study by Levine et al. published in the journal Aging developed DNAm PhenoAge by incorporating clinical measures of phenotypic age (including albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, red blood cell volume, alkaline phosphatase, and white blood cell count) into the epigenetic model. PhenoAge significantly outperformed the original Horvath clock in predicting all-cause mortality, cancer incidence, healthspan, physical functioning, and Alzheimer’s disease across multiple independent cohorts. The key insight was that incorporating clinical phenotypic data into the training algorithm produced an epigenetic biomarker more closely aligned with functional aging than chronological age prediction alone.

The 2021 study by McCrory et al. in The Journals of Gerontology compared four major epigenetic clocks (Horvath, Hannum, PhenoAge, GrimAge) in a cohort of 490 participants from the Irish Longitudinal Study on Ageing. GrimAge outperformed all others, predicting 8 of 9 clinical outcomes including walking speed, frailty, polypharmacy, cognitive performance (MMSE and MOCA scores), and all-cause mortality at 10-year follow-up. GrimAge remained a significant predictor of walking speed, polypharmacy, frailty, and mortality even after adjustment for social and lifestyle factors, demonstrating that epigenetic age provides predictive information beyond what traditional risk factors capture.

DunedinPACE, developed by researchers at Duke University, represents the next generation of epigenetic aging measurement. Rather than estimating a static biological age, DunedinPACE measures the current pace of aging: how many years of biological aging are occurring per calendar year. A DunedinPACE score of 1.0 means the individual is aging at the expected rate. A score below 1.0 indicates slower-than-expected aging; above 1.0 indicates accelerated aging. This metric is particularly valuable for tracking the impact of lifestyle interventions, because it captures changes in aging rate that might take years to appear in static biological age estimates. That is the science. Here is how TruDiagnostic applies it.

What TruDiagnostic Does Well

TruDiagnostic’s primary strength is the breadth and depth of its epigenetic analysis panel. No other consumer test offers as many validated epigenetic clock algorithms in a single report. By including OMICmAge, DunedinPACE, GrimAge, PhenoAge, Horvath, and organ-specific aging measures, TruAge Complete provides a multi-dimensional view of biological aging that no single clock can deliver alone. This redundancy is scientifically valuable because each clock captures different aspects of aging biology.

The DunedinPACE pace-of-aging metric is particularly powerful for longitudinal use. Users who retest after implementing lifestyle changes (improved sleep, nutrition, exercise, stress management) can track whether their rate of aging is decelerating. This creates a feedback loop between behavior and measurable biological outcome that is uniquely compelling for the longevity-focused consumer.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

TruDiagnostic has invested heavily in research validation, contributing to over 15 peer-reviewed publications and partnering with academic researchers studying aging biology. This research commitment distinguishes the company from competitors that rely on published algorithms without contributing to their advancement. The company’s reference database provides population-level context for individual results, allowing users to understand how their biological age compares to others of the same chronological age and demographic profile. HSA and FSA eligibility broadens accessibility for consumers who can use pre-tax health spending accounts to fund the test.

Pricing, Access, and Practical Realities

TruAge Complete costs $499 as a single test. Multi-test packages are available at reduced per-test pricing for users planning longitudinal tracking, which TruDiagnostic recommends every 3 to 6 months. No subscription is required, though the longitudinal model means the effective annual cost for users who retest regularly ranges from $1,000 to $2,000.

The test is HSA and FSA eligible, which is a meaningful financial advantage for users with access to pre-tax health spending accounts. No physician order is required. The at-home finger-prick blood collection is straightforward, and the sample ships to TruDiagnostic’s CLIA-certified laboratory with a prepaid mailer. Results are delivered within 4 to 6 weeks through a secure online portal.

TruDiagnostic is not FDA cleared as a diagnostic device. The results are classified as informational wellness data and should not be used to diagnose, treat, or prevent disease. Users who discover significantly accelerated biological aging should consult a healthcare provider for clinical evaluation. The epigenetic clocks measure methylation patterns that correlate with health outcomes in population studies, but individual results should be interpreted within the context of overall health status.

Who TruDiagnostic Is Best For

TruDiagnostic TruAge Complete is ideal for longevity-focused individuals who want to measure and track their biological age as a core health metric. It serves functional medicine practitioners and their patients who are implementing anti-aging interventions and need an objective biomarker to assess effectiveness. Biohackers and quantified self enthusiasts who want the most comprehensive epigenetic data available will find TruAge Complete the gold standard in its category. Researchers studying aging biology at an individual level can use the multi-algorithm panel to explore different dimensions of their own aging trajectory.

Those who should consider alternatives include budget-conscious consumers, for whom the Elysium Index ($299) provides a more affordable entry point into epigenetic age testing with a narrower but still informative methylation analysis. Users who want genetic ancestry and inherited risk information should look at 23andMe or Nebula Genomics instead, as epigenetic testing and genetic testing measure fundamentally different things. Anyone expecting a diagnostic result or medical prescription based on the test will be disappointed; TruAge Complete provides data and context, not clinical guidance. Individuals who are not prepared to retest should understand that a single snapshot has limited utility compared to longitudinal tracking, where TruDiagnostic’s value proposition is strongest.

How TruDiagnostic Compares

Elysium Index ($299) offers a DNA methylation-based biological age test developed in collaboration with scientists who contributed to the foundational epigenetic clock research. Elysium is more affordable but provides fewer clock algorithms and less detailed reporting than TruAge Complete. GlycanAge ($299 to $499) measures biological age through a fundamentally different biomarker, glycan patterns on immunoglobulin G antibodies, providing a complementary view of immune system aging that methylation-based tests do not capture.

myDNAge ($299 to $499) from Zymo Research offers the original Horvath epigenetic clock with the unique option of using a urine sample instead of blood. Chronomics ($299 to $499) provides methylation-based biological age with a focus on longitudinal lifestyle impact tracking. Among all consumer epigenetic tests, TruDiagnostic offers the most algorithms, the deepest reporting, and the strongest research validation track record, which justifies its premium pricing for users who want the most comprehensive available data.

Compared to genetic testing services (23andMe, Nebula), epigenetic testing occupies a complementary rather than competing space. Genetics tells you what predispositions you inherited; epigenetics tells you how your body is actually aging right now. The most comprehensive approach combines both: WGS for the inherited blueprint, epigenetic age testing for the dynamic state of the system.

Limitations and Open Questions

Epigenetic clocks, despite strong population-level validation, carry meaningful uncertainty at the individual level. The standard error for most clocks is approximately 3 to 5 years, meaning that a reported biological age of 45 might reflect a true biological age anywhere from 40 to 50. For longitudinal tracking, this uncertainty is less problematic because the direction of change is more reliable than the absolute number, but users should not over-interpret small changes between tests.

The field is evolving rapidly, and the “best” clock algorithm changes as new research is published. TruDiagnostic’s multi-algorithm approach mitigates this by providing results from several clocks, but it also means that users must navigate potentially conflicting results (one clock showing accelerated aging while another shows deceleration). Interpreting multi-clock reports requires either biological literacy or professional guidance.

The causal relationship between methylation changes and aging outcomes remains an active area of research. While epigenetic age acceleration is robustly associated with mortality and disease risk in observational studies, it is not yet proven that interventions that reverse methylation patterns actually extend lifespan. The assumption that “younger epigenetic age equals longer life” is plausible but not yet confirmed by randomized controlled trials. Finally, the $499 price point and the recommendation for quarterly retesting make TruAge Complete a significant ongoing investment that may not be accessible to all consumers.

What This Means for Your Health

Epigenetic age testing represents the frontier of longevity measurement. Within Healthcare Discovery‘s framework, it provides the most direct readout currently available of how well your body is navigating the biological aging process that ultimately drives the Four Shadows: cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction. The McCrory et al. study demonstrated that GrimAge predicts frailty, cognitive decline, polypharmacy, and mortality independently of traditional risk factors, meaning that epigenetic age captures information that blood panels and physical exams do not.

The actionable power of the test lies in its longitudinal use. A single snapshot tells you roughly where you stand. Repeated measurements reveal whether your interventions are working. Are three months of improved sleep, targeted nutrition, and consistent resistance training decelerating your pace of aging? DunedinPACE can answer that question more directly than any other consumer biomarker currently available.

The Five Pillars, Nutrition, Sleep, Movement, Breathwork, and Mindset, are the primary tools for influencing epigenetic age. Research consistently shows that caloric quality, sleep duration and regularity, exercise intensity and consistency, stress management, and social connection all affect DNA methylation patterns. TruAge Complete does not tell you what to do; it tells you whether what you are doing is working at the molecular level. For the longevity-focused individual, that feedback loop may be the most valuable health investment available today.

Frequently Asked Questions

What is the difference between biological age and chronological age?
Chronological age is the number of years since birth. Biological age is a measure of how old your cells and tissues appear based on molecular biomarkers, specifically DNA methylation patterns in epigenetic testing. Two people of the same chronological age can have significantly different biological ages depending on genetics, lifestyle, environment, and health history. The McCrory et al. 2021 study showed that biological age measured by GrimAge predicts mortality, frailty, and cognitive decline more accurately than chronological age.

How often should I take the TruAge test?
TruDiagnostic recommends retesting every 3 to 6 months for longitudinal tracking. This interval allows sufficient time for lifestyle interventions to produce measurable changes in DNA methylation patterns. A single test provides a baseline snapshot, but the test’s greatest value emerges when used longitudinally to track the impact of nutrition, exercise, sleep, and stress management changes over time. At $499 per test, users should budget $1,000 to $2,000 annually for regular monitoring.

Is TruDiagnostic TruAge covered by insurance?
TruAge Complete is not typically covered by health insurance, as it is classified as a wellness test rather than a diagnostic procedure. However, the test is HSA and FSA eligible, meaning users with access to pre-tax health spending accounts can use those funds to pay for the test. This can represent a 20% to 35% effective discount depending on the user’s tax bracket.

What is DunedinPACE and why does it matter?
DunedinPACE, developed by researchers at Duke University, measures the current pace of biological aging rather than estimating a static biological age. A score of 1.0 means aging at the expected rate; below 1.0 means slower aging; above 1.0 means accelerated aging. This metric is uniquely valuable for tracking the real-time impact of lifestyle interventions because it captures changes in aging velocity that static biological age estimates may take years to reflect.

Can lifestyle changes actually reverse epigenetic age?
Observational studies and some interventional trials have shown that specific lifestyle modifications, including improved nutrition, regular exercise, quality sleep, and stress management, are associated with favorable changes in DNA methylation patterns and reductions in epigenetic age acceleration. However, large-scale randomized controlled trials proving that epigenetic age reversal directly extends lifespan have not yet been completed. The evidence is promising and biologically plausible, but the causal chain from methylation change to lifespan extension remains an active area of research.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.